The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Repligen said today it has acquired TangenX Technology from Novasep Holding for $39 million in a deal that adds to the bioprocessing company’s single-use technology offerings and broadens its ...

WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Tangential Flow Filtration market is dominated by a mix of global bioprocessing leaders and specialized filtration technology innovators. Companies are ...

Investing.com - KeyBanc reiterated its Overweight rating and $220.00 price target on Repligen (NASDAQ:RGEN) on Tuesday, highlighting the company’s differentiated filtration portfolio. Currently ...

A therapeutic protein or monoclonal antibody (mAb) can be turned into an effective therapy and a revenue-generating product only if it can be efficiently filtered from the process stream. If a product ...

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced Novasign and Repligen have entered into a strategic partnership to develop and integrate ...